BB vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

BB

46.2
AI Score
VS
CLOV Wins

CLOV

48.9
AI Score

Investment Advisor Scores

BB

46score
Recommendation
HOLD

CLOV

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BB CLOV Winner
Forward P/E 43.4783 81.9672 BB
PEG Ratio 2.2115 0 Tie
Revenue Growth 25.6% 62.0% CLOV
Earnings Growth 216.3% 0.0% BB
Tradestie Score 46.2/100 48.9/100 CLOV
Profit Margin 10.3% -2.6% BB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BB 1M: -33.6% · 3M: +57.4% CLOV 1M: -22.6% · 3M: +51.6%

Current Technical Phase

BB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.5 · Price: $8.50

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.3 · Price: $4.17

Fundamentals Snapshot

Metric BB CLOV
Market Cap
Forward P/E 51.7 41.7
Trailing P/E 84.4
Revenue (TTM)
Revenue Growth 0.3% 0.6%
Gross Margin 0.8% 0.2%
Operating Margin 0.1% 0.0%
EPS 0.10 -0.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.